Main Menu

Publications

Publications Highlights View all by category

Types of Publications


Journal Articles

Curcean, A. Curcean, S. Rescigno, P. Dafydd, D.A. Tree, A. Reid, A. Koh, D.-. Sohaib, A. Tunariu, N. Shur, J. (2022). Imaging features of the evolving patterns of metastatic prostate cancer. , Vol.77 (2), pp. 88-95.  show abstract

Sritharan, K. Tree, A. (2022). MR-guided radiotherapy for prostate cancer: state of the art and future perspectives. The british journal of radiology, Vol.95 (1131), pp. 20210800-?.  show abstract

Murray, J.R. Sankey, P. Tree, A.C. Hall, E. (2022). PEARLS: Is Our Use of Prostate-specific Membrane Antigen Positron Emission Tomography-Computed Tomography Meaningful for Our Patients?. Clinical oncology, .

Keall, P.J. Brighi, C. Glide-Hurst, C. Liney, G. Liu, P.Z. Lydiard, S. Paganelli, C. Pham, T. Shan, S. Tree, A.C. van der Heide, U.A. Waddington, D.E. Whelan, B. (2022). Integrated MRI-guided radiotherapy - opportunities and challenges. Nature reviews. clinical oncology, .  show abstract

Alexander, S.E. McNair, H.A. Oelfke, U. Huddart, R. Murray, J. Pathmanathan, A. Patel, P. Sritharan, K. van As, N. Tree, A.C. (2022). Prostate Volume Changes during Extreme and Moderately Hypofractionated Magnetic Resonance Image-guided Radiotherapy. Clinical oncology (royal college of radiologists (great britain)), .  show abstract

Westley, R. Hall, E. Tree, A. (2022). HERMES: Delivery of a Speedy Prostate Cancer Treatment. Clinical oncology (royal college of radiologists (great britain)), .

Hall, W.A. Paulson, E. Davis, B.J. Spratt, D.E. Morgan, T.M. Dearnaley, D. Tree, A.C. Efstathiou, J.A. Harisinghani, M. Jani, A.B. Buyyounouski, M.K. Pisansky, T.M. Tran, P.T. Karnes, R.J. Chen, R.C. Cury, F.L. Michalski, J.M. Rosenthal, S.A. Koontz, B.F. Wong, A.C. Nguyen, P.L. Hope, T.A. Feng, F. Sandler, H.M. Lawton, C.A. (2021). NRG Oncology Updated International Consensus Atlas on Pelvic Lymph Node Volumes for Intact and Postoperative Prostate Cancer. International journal of radiation oncology, biology, physics, Vol.109 (1), pp. 174-185.  show abstract

Mohajer, J. Dunlop, A. Mitchell, A. Goodwin, E. Nill, S. Oelfke, U. Tree, A. (2021). Feasibility of MR-guided ultrahypofractionated radiotherapy in 5, 2 or 1 fractions for prostate cancer. Clinical and translational radiation oncology, Vol.26, pp. 1-7.  show abstract

Brand, D.H. Brüningk, S.C. Wilkins, A. Fernandez, K. Naismith, O. Gao, A. Syndikus, I. Dearnaley, D.P. Tree, A.C. van As, N. Hall, E. Gulliford, S. CHHiP Trial Management Group, (2021). Estimates of Alpha/Beta (α/β) Ratios for Individual Late Rectal Toxicity Endpoints: An Analysis of the CHHiP trial. International journal of radiation oncology, biology, physics, .  show abstract

de Mol van Otterloo, S.R. Christodouleas, J.P. Blezer, E.L. Akhiat, H. Brown, K. Choudhury, A. Eggert, D. Erickson, B.A. Daamen, L.A. Faivre-Finn, C. Fuller, C.D. Goldwein, J. Hafeez, S. Hall, E. Harrington, K.J. van der Heide, U.A. Huddart, R.A. Intven, M.P. Kirby, A.M. Lalondrelle, S. McCann, C. Minsky, B.D. Mook, S. Nowee, M.E. Oelfke, U. Orrling, K. Philippens, M.E. Sahgal, A. Schultz, C.J. Tersteeg, R.J. Tijssen, R.H. Tree, A.C. van Triest, B. Tseng, C.-. Hall, W.A. Verkooijen, H.M. (2021). Patterns of Care, Tolerability, and Safety of the First Cohort of Patients Treated on a Novel High-Field MR-Linac Within the MOMENTUM Study: Initial Results From a Prospective Multi-Institutional Registry. International journal of radiation oncology*biology*physics, Vol.111 (4), pp. 867-875.

Sritharan, K. Rieu, R. Tree, A. (2021). A narrative review of oligometastatic prostate cancer-an evolving paradigm. Annals of palliative medicine, .  show abstract

Tree, A.C. van As, N.J. (2021). Single dose prostate radiotherapy - a step too far?. Nature reviews. urology, .

Liu, W.K. Patel, R. Crawford, R. Ayres, B. Watkin, N. Tree, A. Pickering, L. Patel, H.R. Ashfar, M. (2021). Longitudinal cohort analysis of patients with metastatic penile cancer treated in a large quaternary academic centre. Journal of clinical urology, , pp. ?-? (10).

Corradini, S. Alongi, F. Andratschke, N. Azria, D. Bohoudi, O. Boldrini, L. Bruynzeel, A. Hörner-Rieber, J. Jürgenliemk-Schulz, I. Lagerwaard, F. McNair, H. Raaymakers, B. Schytte, T. Tree, A. Valentini, V. Wilke, L. Zips, D. Belka, C. (2021). ESTRO-ACROP recommendations on the clinical implementation of hybrid MR-linac systems in radiation oncology. Radiotherapy and oncology : journal of the european society for therapeutic radiology and oncology, Vol.159, pp. 146-154.  show abstract

de Mol van Otterloo, S.R. Christodouleas, J.P. Blezer, E.L. Akhiat, H. Brown, K. Choudhury, A. Eggert, D. Erickson, B.A. Faivre-Finn, C. Fuller, C.D. Goldwein, J. Hafeez, S. Hall, E. Harrington, K.J. van der Heide, U.A. Huddart, R.A. Intven, M.P. Kirby, A.M. Lalondrelle, S. McCann, C. Minsky, B.D. Mook, S. Nowee, M.E. Oelfke, U. Orrling, K. Sahgal, A. Sarmiento, J.G. Schultz, C.J. Tersteeg, R.J. Tijssen, R.H. Tree, A.C. van Triest, B. Hall, W.A. Verkooijen, H.M. (2020). The MOMENTUM Study: An International Registry for the Evidence-Based Introduction of MR-Guided Adaptive Therapy. Frontiers in oncology, Vol.10, pp. 1328-?.  show abstract

Tree, A.C. Dearnaley, D.P. (2020). Seven or less Fractions is Not the Standard of Care for Intermediate-Risk Prostate Cancer. Clinical oncology (royal college of radiologists (great britain)), Vol.32 (3), pp. 175-180.  show abstract

Murray, J.R. Tree, A.C. Alexander, E.J. Sohaib, A. Hazell, S. Thomas, K. Gunapala, R. Parker, C.C. Huddart, R.A. Gao, A. Truelove, L. McNair, H.A. Blasiak-Wal, I. deSouza, N.M. Dearnaley, D. (2020). Standard and Hypofractionated Dose Escalation to Intraprostatic Tumor Nodules in Localized Prostate Cancer: Efficacy and Toxicity in the DELINEATE Trial. International journal of radiation oncology, biology, physics, Vol.106 (4), pp. 715-724.  show abstract

Barnes, H. Mohajer, J. Dunlop, A. Adair Smith, G. Herbert, T. Lawes, R. Tree, A. McNair, H. (2020). Laser-free pelvic alignment in an online adaptive radiotherapy environment. Technical innovations & patient support in radiation oncology, Vol.13, pp. 21-23.  show abstract

Dunlop, A. Mitchell, A. Tree, A. Barnes, H. Bower, L. Chick, J. Goodwin, E. Herbert, T. Lawes, R. McNair, H. McQuaid, D. Mohajer, J. Nilawar, R. Pathmanathan, A. Smith, G. Hanson, I. Nill, S. Oelfke, U. (2020). Daily adaptive radiotherapy for patients with prostate cancer using a high field MR-linac: Initial clinical experiences and assessment of delivered doses compared to a C-arm linac. Clinical and translational radiation oncology, Vol.23, pp. 35-42.  show abstract

Grimwood, A. Rivaz, H. Zhou, H. McNair, H.A. Jakubowski, K. Bamber, J.C. Tree, A.C. Harris, E.J. (2020). Improving 3D ultrasound prostate localisation in radiotherapy through increased automation of interfraction matching. Radiotherapy and oncology : journal of the european society for therapeutic radiology and oncology, Vol.149, pp. 134-141.  show abstract

Menten, M.J. Mohajer, J.K. Nilawar, R. Bertholet, J. Dunlop, A. Pathmanathan, A.U. Moreau, M. Marshall, S. Wetscherek, A. Nill, S. Tree, A.C. Oelfke, U. (2020). Automatic reconstruction of the delivered dose of the day using MR-linac treatment log files and online MR imaging. Radiotherapy and oncology : journal of the european society for therapeutic radiology and oncology, Vol.145, pp. 88-94.  show abstract

Syndikus, I. Cruickshank, C. Staffurth, J. Tree, A. Henry, A. Naismith, O. Mayles, H. Snelson, N. Hassan, S. Brown, S. Porta, N. Griffin, C. Hall, E. (2020). PIVOTALboost: A phase III randomised controlled trial of prostate and pelvis versus prostate alone radiotherapy with or without prostate boost (CRUK/16/018). Clinical and translational radiation oncology, Vol.25, pp. 22-28.  show abstract

Sundahl, N. Tree, A. Parker, C. (2020). The Emerging Role of Local Therapy in Metastatic Prostate Cancer. Current oncology reports, Vol.22 (1), pp. 2-?.  show abstract

Ager, M. Njoku, K. Serra, M. Robinson, A. Pickering, L. Afshar, M. Vyas, L. Eardley, I. Kayes, O. Elmamoun, M. Khoo, V. Ayres, B. Henry, A. Watkin, N. Tree, A.C. (2020). Long-term multicentre experience of adjuvant radiotherapy for pN3 squamous cell carcinoma of the penis. Bju international, .  show abstract

Pathmanathan, A.U. McNair, H.A. Schmidt, M.A. Brand, D.H. Delacroix, L. Eccles, C.L. Gordon, A. Herbert, T. van As, N.J. Huddart, R.A. Tree, A.C. (2019). Comparison of prostate delineation on multimodality imaging for MR-guided radiotherapy. The british journal of radiology, Vol.92 (1095), pp. 20180948-?.  show abstract

Pathmanathan, A.U. Schmidt, M.A. Brand, D.H. Kousi, E. van As, N.J. Tree, A.C. (2019). Improving fiducial and prostate capsule visualization for radiotherapy planning using MRI. Journal of applied clinical medical physics, Vol.20 (3), pp. 27-36.  show abstract

Bashir, U. Tree, A. Mayer, E. Levine, D. Parker, C. Dearnaley, D. Oyen, W.J. (2019). Impact of Ga-68-PSMA PET/CT on management in prostate cancer patients with very early biochemical recurrence after radical prostatectomy. European journal of nuclear medicine and molecular imaging, Vol.46 (4), pp. 901-907.  show abstract

de Muinck Keizer, D.M. Pathmanathan, A.U. Andreychenko, A. Kerkmeijer, L.G. van der Voort van Zyp, J.R. Tree, A.C. van den Berg, C.A. de Boer, J.C. (2019). Fiducial marker based intra-fraction motion assessment on cine-MR for MR-linac treatment of prostate cancer. Physics in medicine and biology, Vol.64 (7), pp. 07NT02-?.  show abstract

Brand, D.H. Tree, A.C. Ostler, P. van der Voet, H. Loblaw, A. Chu, W. Ford, D. Tolan, S. Jain, S. Martin, A. Staffurth, J. Camilleri, P. Kancherla, K. Frew, J. Chan, A. Dayes, I.S. Henderson, D. Brown, S. Cruickshank, C. Burnett, S. Duffton, A. Griffin, C. Hinder, V. Morrison, K. Naismith, O. Hall, E. van As, N. PACE Trial Investigators, (2019). Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial. The lancet. oncology, Vol.20 (11), pp. 1531-1543.  show abstract

Patel, P.H. Palma, D. McDonald, F. Tree, A.C. (2019). The Dandelion Dilemma Revisited for Oligoprogression: Treat the Whole Lawn or Weed Selectively?. Clinical oncology (royal college of radiologists (great britain)), Vol.31 (12), pp. 824-833.  show abstract

De Bleser, E. Jereczek-Fossa, B.A. Pasquier, D. Zilli, T. Van As, N. Siva, S. Fodor, A. Dirix, P. Gomez-Iturriaga, A. Trippa, F. Detti, B. Ingrosso, G. Triggiani, L. Bruni, A. Alongi, F. Reynders, D. De Meerleer, G. Surgo, A. Loukili, K. Miralbell, R. Silva, P. Chander, S. Di Muzio, N.G. Maranzano, E. Francolini, G. Lancia, A. Tree, A. Deantoni, C.L. Ponti, E. Marvaso, G. Goetghebeur, E. Ost, P. (2019). Metastasis-directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer: A Multi-institutional Analysis Comparing the Outcome and Toxicity of Stereotactic Body Radiotherapy and Elective Nodal Radiotherapy. European urology, Vol.76 (6), pp. 732-739.  show abstract

Brand, D.H. Parker, J.I. Dearnaley, D.P. Eeles, R. Huddart, R. Khoo, V. Murray, J. Suh, Y.-. Tree, A.C. van As, N. Parker, C. (2019). Patterns of recurrence after prostate bed radiotherapy. Radiotherapy and oncology : journal of the european society for therapeutic radiology and oncology, Vol.141, pp. 174-180.  show abstract

Tree, A. Dearnaley, D. (2018). Randomised Controlled Trials Remain the Key to Progress in Localised Prostate Cancer. European urology, Vol.73 (1), pp. 21-22.

Hanna, G.G. Murray, L. Patel, R. Jain, S. Aitken, K.L. Franks, K.N. van As, N. Tree, A. Hatfield, P. Harrow, S. McDonald, F. Ahmed, M. Saran, F.H. Webster, G.J. Khoo, V. Landau, D. Eaton, D.J. Hawkins, M.A. (2018). UK Consensus on Normal Tissue Dose Constraints for Stereotactic Radiotherapy. Clinical oncology (royal college of radiologists (great britain)), Vol.30 (1), pp. 5-14.  show abstract

Pathmanathan, A.U. van As, N.J. Kerkmeijer, L.G. Christodouleas, J. Lawton, C.A. Vesprini, D. van der Heide, U.A. Frank, S.J. Nill, S. Oelfke, U. van Herk, M. Li, X.A. Mittauer, K. Ritter, M. Choudhury, A. Tree, A.C. (2018). Magnetic Resonance Imaging-Guided Adaptive Radiation Therapy: A "Game Changer" for Prostate Treatment?. International journal of radiation oncology, biology, physics, Vol.100 (2), pp. 361-373.  show abstract

Henderson, D.R. Tree, A.C. Harrington, K.J. van As, N.J. (2018). Dosimetric Implications of Computerised Tomography-Only versus Magnetic Resonance-Fusion Contouring in Stereotactic Body Radiotherapy for Prostate Cancer. Medicines (basel, switzerland), Vol.5 (2).  show abstract

Tree, A.C. Jones, K. Hafeez, S. Sharabiani, M.T. Harrington, K.J. Lalondrelle, S. Ahmed, M. Huddart, R.A. (2018). Dose-limiting Urinary Toxicity With Pembrolizumab Combined With Weekly Hypofractionated Radiation Therapy in Bladder Cancer. International journal of radiation oncology, biology, physics, Vol.101 (5), pp. 1168-1171.  show abstract

Henderson, D.R. Murray, J.R. Gulliford, S.L. Tree, A.C. Harrington, K.J. Van As, N.J. (2018). An Investigation of Dosimetric Correlates of Acute Toxicity in Prostate Stereotactic Body Radiotherapy: Dose to Urinary Trigone is Associated with Acute Urinary Toxicity. Clinical oncology (royal college of radiologists (great britain)), Vol.30 (9), pp. 539-547.  show abstract

Grimwood, A. McNair, H.A. O'Shea, T.P. Gilroy, S. Thomas, K. Bamber, J.C. Tree, A.C. Harris, E.J. (2018). In Vivo Validation of Elekta's Clarity Autoscan for Ultrasound-based Intrafraction Motion Estimation of the Prostate During Radiation Therapy. International journal of radiation oncology, biology, physics, Vol.102 (4), pp. 912-921.  show abstract

Tree, A.C. Huddart, R. Choudhury, A. (2018). Magnetic Resonance-guided Radiotherapy - Can We Justify More Expensive Technology?. Clinical oncology (royal college of radiologists (great britain)), Vol.30 (11), pp. 677-679.

Benjamin, L.C. Tree, A.C. Dearnaley, D.P. (2017). The Role of Hypofractionated Radiotherapy in Prostate Cancer. Curr oncol rep, Vol.19 (4), pp. 30-30.  show abstract

Bianchini, D. Lorente, D. Rescigno, P. Zafeiriou, Z. Psychopaida, E. O'Sullivan, H. Alaras, M. Kolinsky, M. Sumanasuriya, S. Sousa Fontes, M. Mateo, J. Perez Lopez, R. Tunariu, N. Fotiadis, N. Kumar, P. Tree, A. Van As, N. Khoo, V. Parker, C. Eeles, R. Thompson, A. Dearnaley, D. de Bono, J.S. (2017). Effect on Overall Survival of Locoregional Treatment in a Cohort of De Novo Metastatic Prostate Cancer Patients: A Single Institution Retrospective Analysis From the Royal Marsden Hospital. Clinical genitourinary cancer, Vol.15 (5), pp. e801-e807.  show abstract

Patrikidou, A. Uccello, M. Tree, A. Parker, C. Attard, G. Eeles, R. Khoo, V. van As, N. Huddart, R. Dearnaley, D. Reid, A. (2017). Upfront Docetaxel in the Post-STAMPEDE World: Lessons from an Early Evaluation of Non-trial Usage in Hormone-Sensitive Prostate Cancer. Clinical oncology (royal college of radiologists (great britain)), Vol.29 (10), pp. e174-e175.

Ost, P. Jereczek-Fossa, B.A. As, N.V. Zilli, T. Muacevic, A. Olivier, K. Henderson, D. Casamassima, F. Orecchia, R. Surgo, A. Brown, L. Tree, A. Miralbell, R. De Meerleer, G. (2016). Progression-free Survival Following Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Treatment-naive Recurrence: A Multi-institutional Analysis. European urology, Vol.69 (1), pp. 9-12.

Henderson, D.R. Murray, J.R. Tree, A.C. Riley, U. Rosenfelder, N.A. Murray, D. Khoo, V.S. van As, N.J. (2016). Targeted Antibiotic Prophylaxis for Transrectal Fiducial Marker Insertion for Prostate Radiotherapy. Clinical oncology, Vol.28 (3), pp. 226-227.

McPartlin, A.J. Li, X.A. Kershaw, L.E. Heide, U. Kerkmeijer, L. Lawton, C. Mahmood, U. Pos, F. van As, N. van Herk, M. Vesprini, D. van der Voort van Zyp, J. Tree, A. Choudhury, A. MR-Linac consortium, (2016). MRI-guided prostate adaptive radiotherapy - A systematic review. Radiotherapy and oncology : journal of the european society for therapeutic radiology and oncology, Vol.119 (3), pp. 371-380.  show abstract

Bedford, J.L. Smyth, G. Hanson, I.M. Tree, A.C. Dearnaley, D.P. Hansen, V.N. (2016). Quality of treatment plans and accuracy of in vivo portal dosimetry in hybrid intensity-modulated radiation therapy and volumetric modulated arc therapy for prostate cancer. Radiotherapy and oncology : journal of the european society for therapeutic radiology and oncology, Vol.120 (2), pp. 320-326.  show abstract

Pathmanathan, A.U. Alexander, E.J. Huddart, R.A. Tree, A.C. (2016). The delineation of intraprostatic boost regions for radiotherapy using multimodality imaging. Future oncology (london, england), Vol.12 (21), pp. 2495-2511.  show abstract

Henderson, D. Murray, J. Tree, A. Riley, U. Murray, D. van As, N. (2015). Fiducial Marker Insertion for Image-guided Radiotherapy for Prostate Cancer: What is the Infection Rate and can Targeted Antibiotic Prophylaxis Reduce this?. Clinical oncology, Vol.27 (3), pp. e5-e5.

Henderson, D.R. Tree, A.C. van As, N.J. (2015). Stereotactic Body Radiotherapy for Prostate Cancer. Clinical oncology, Vol.27 (5), pp. 270-279.

Aitken, K. Tree, A. Thomas, K. Nutting, C. Hawkins, M. Tait, D. Mandeville, H. Ahmed, M. Lalondrelle, S. Miah, A. Taylor, A. Ross, G. Khoo, V. van As, N. (2015). Initial UK Experience of Stereotactic Body Radiotherapy for Extracranial Oligometastases: Can We Change the Therapeutic Paradigm?. Clinical oncology, Vol.27 (7), pp. 411-419.

Tree, A. Ostler, P. van As, N. (2014). New Horizons and Hurdles for UK Radiotherapy: Can Prostate Stereotactic Body Radiotherapy Show the Way?. Clinical oncology, Vol.26 (1), pp. 1-3.

Tree, A. Ostler, P. Hoskin, P. Dankulchai, P. Khoo, V. van As, N. (2014). First UK Cohort of Prostate Stereotactic Body Radiotherapy (SBRT): Acute Toxicity and Early Prostate-specific Antigen (PSA) Outcomes. Clinical oncology, Vol.26 (2), pp. e7-e7.

Tree, A.C. Khoo, V.S. van As, N.J. Partridge, M. (2014). Is Biochemical Relapse-free Survival After Profoundly Hypofractionated Radiotherapy Consistent with Current Radiobiological Models?. Clinical oncology, Vol.26 (4), pp. 216-229.

Tree, A. Siu, B. Townsend-Thorn, D. Murray, D. Riley, U. Khoo, V. van As, N. (2014). The Incidence of Ciprofloxacin Resistance in Patients Undergoing Gold Seed Insertion for Image-guided Prostate Radiotherapy. Clinical oncology, Vol.26, pp. S8-S8.

Tree, A.C. Ostler, P. Hoskin, P. Dankulchai, P. Nariyangadu, P. Hughes, R.J. Wells, E. Taylor, H. Khoo, V.S. van As, N.J. (2014). Prostate Stereotactic Body Radiotherapy — First UK Experience. Clinical oncology, Vol.26 (12), pp. 757-761.

Tree, A.C. Khoo, V.S. Eeles, R.A. Ahmed, M. Dearnaley, D.P. Hawkins, M.A. Huddart, R.A. Nutting, C.M. Ostler, P.J. van As, N.J. (2013). Stereotactic body radiotherapy for oligometastases. Lancet oncol, Vol.14 (1), pp. e28-e37.  show abstract

Tree, A. Wells, E. Khoo, V. van As, N. (2013). Hypofractionated Radiotherapy with Cyberknife for Localised Prostate Cancer: Early Experience. Clinical oncology, Vol.25 (4), pp. e72-e73.

Tree, A.C. Alexander, E.J. Van As, N.J. Dearnaley, D.P. Khoo, V. (2013). Biological Dose Escalation and Hypofractionation: What is There to be Gained and How Will it Best be Done?. Clinical oncology, Vol.25 (8), pp. 483-498.

Tree, A. Jones, C. Sohaib, A. Khoo, V. van As, N. (2013). Prostate stereotactic body radiotherapy with simultaneous integrated boost: which is the best planning method?. Radiation oncology, Vol.8 (1).

Creak, A.L. Tree, A. Saran, F. (2011). Radiotherapy Planning in High-grade Gliomas: a Survey of Current UK Practice. Clinical oncology, Vol.23 (3), pp. 189-198.

Partridge, M. Tree, A. Brock, J. McNair, H. Fernandez, E. Panakis, N. Brada, M. (2009). Improvement in tumour control probability with active breathing control and dose escalation: A modelling study. Radiotherapy and oncology, Vol.91 (3), pp. 325-329.

Alexander, S.E. Kinsella, J. McNair, H.A. Tree, A.C. National survey of fiducial marker insertion for prostate image guided radiotherapy. Radiography (london, england : 1995), Vol.24 (4), pp. 275-282.  show abstract

Zaorsky, N.G. Yu, J.B. McBride, S.M. Dess, R.T. Jackson, W.C. Mahal, B.A. Chen, R. Choudhury, A. Henry, A. Syndikus, I. Mitin, T. Tree, A. Kishan, A.U. Spratt, D.E. Prostate Cancer Radiation Therapy Recommendations in Response to COVID-19. Advances in radiation oncology, Vol.5 (4), pp. 659-665.  show abstract

Murray, J. Tree, A.C. Prostate cancer - Advantages and disadvantages of MR-guided RT. Clinical and translational radiation oncology, Vol.18, pp. 68-73.  show abstract

Ost, P. Jereczek-Fossa, B.A. Van As, N. Zilli, T. Tree, A. Henderson, D. Orecchia, R. Casamassima, F. Surgo, A. Miralbell, R. De Meerleer, G. Pattern of Progression after Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Nodal Recurrences. Clinical oncology (royal college of radiologists (great britain)), Vol.28 (9), pp. e115-e120.  show abstract

Nicholls, L. Suh, Y.-. Chapman, E. Henderson, D. Jones, C. Morrison, K. Sohaib, A. Taylor, H. Tree, A. van As, N. Stereotactic radiotherapy with focal boost for intermediate and high-risk prostate cancer: Initial results of the SPARC trial. Clinical and translational radiation oncology, Vol.25, pp. 88-93.  show abstract

Zaorsky, N.G. Yu, J.B. McBride, S.M. Dess, R.T. Jackson, W.C. Mahal, B.A. Chen, R. Choudhury, A. Henry, A. Syndikus, I. Mitin, T. Tree, A. Kishan, A.U. Spratt, D.E. Prostate Cancer Radiation Therapy Recommendations in Response to COVID-19. Advances in radiation oncology, Vol.5 (Suppl 1), pp. 26-32.  show abstract

Jereczek-Fossa, B.A. Marvaso, G. Zaffaroni, M. Gugliandolo, S.G. Zerini, D. Corso, F. Gandini, S. Alongi, F. Bossi, A. Cornford, P. De Bari, B. Fonteyne, V. Hoskin, P. Pieters, B.R. Tree, A.C. Arcangeli, S. Fuller, D.B. Franzese, C. Hannoun-Levi, J.-. Janoray, G. Kerkmeijer, L. Kwok, Y. Livi, L. Loi, M. Miralbell, R. Pasquier, D. Pinkawa, M. Scher, N. Scorsetti, M. Shelan, M. Toledano, A. van As, N. Vavassori, A. Zilli, T. Pepa, M. Ost, P. on the behalf of the European Society for Radiotherapy, O.N. Salvage stereotactic body radiotherapy (SBRT) for intraprostatic relapse after prostate cancer radiotherapy: An ESTRO ACROP Delphi consensus. Cancer treatment reviews, Vol.98, pp. 102206-?.  show abstract

Hijab, A. Curcean, S. Tunariu, N. Tovey, H. Alonzi, R. Staffurth, J. Blackledge, M.D. Padhani, A.R. Tree, A. Stidwill, H. Finch, J. Chatfield, P. Perry, S. Koh, D. Hall, E. Parker, C.C. Fracture risk in men with metastatic prostate cancer treated with radium-223. Clinical genitourinary cancer, .

Alexander, S.E. Booth, L. Delacroix, L. Gordon, A. Kirkpatrick, N. Tree, A.C. Evaluation of a urology specialist therapeutic radiographer implemented radiotherapy pathway for prostate cancer patients. Radiography (london, england : 1995), Vol.27 (2), pp. 430-436.  show abstract

Grimwood, A. Thomas, K. Kember, S. Aldis, G. Lawes, R. Brigden, B. Francis, J. Henegan, E. Kerner, M. Delacroix, L. Gordon, A. Tree, A. Harris, E.J. McNair, H.A. Factors affecting accuracy and precision in ultrasound guided radiotherapy. Physics and imaging in radiation oncology, Vol.18, pp. 68-77.  show abstract

Hall, W.A. Paulson, E. Li, X.A. Erickson, B. Schultz, C. Tree, A. Awan, M. Low, D.A. McDonald, B.A. Salzillo, T. Glide-Hurst, C.K. Kishan, A.U. Fuller, C.D. Magnetic resonance linear accelerator technology and adaptive radiation therapy: An overview for clinicians. Ca: a cancer journal for clinicians, Vol.72 (1), pp. 34-56.  show abstract

Tree, A. Griffin, C. Syndikus, I. Birtle, A. Choudhury, A. Graham, J. Ferguson, C. Khoo, V. Malik, Z. O'Sullivan, J. Panades, M. Parker, C. Rimmer, Y. Scrase, C. Staffurth, J. Dearnaley, D. Hall, E. Non-randomised comparison of efficacy and side effects of bicalutamide compared with LHRH analogues in combination with radiotherapy in the CHHiP trial. International journal of radiation oncology*biology*physics, .

Diez, P. Hanna, G.G. Aitken, K.L. van As, N. Carver, A. Colaco, R.J. Conibear, J. Dunne, E.M. Eaton, D.J. Franks, K.N. Good, J.S. Harrow, S. Hatfield, P. Hawkins, M.A. Jain, S. McDonald, F. Patel, R. Rackley, T. Sanghera, P. Tree, A. Murray, L. UK 2022 Consensus on Normal Tissue Dose-Volume Constraints for Oligometastatic, Primary Lung and Hepatocellular Carcinoma Stereotactic Ablative Radiotherapy. Clinical oncology (royal college of radiologists (great britain)), Vol.34 (5), pp. 288-300.  show abstract

Patel, P.H. Tunariu, N. Levine, D.S. de Bono, J.S. Eeles, R.A. Khoo, V. Murray, J. Parker, C.C. Pathmanathan, A. Reid, A. van As, N. Tree, A.C. Oligoprogression in Metastatic, Castrate-Resistant Prostate Cancer—Prevalence and Current Clinical Practice. Frontiers in oncology, Vol.12.  show abstract

Aggarwal, A. Han, L. Tree, A. Lewis, D. Roques, T. Sangar, V. van der Meulen, J. Impact of centralisation of prostate cancer services on the choice of radical treatment. Bju international, .


Conferences

Henderson, D.R.Tree, A.Taylor, H.Khoo, V.Van As, N.J. (2015). Oligometastatic prostate cancer: An evaluation of stereotactic body radiotherapy (SBRT) as an alternative to palliative androgen deprivation therapy., Journal of Clinical Oncology, Vol.33 (7_suppl), p.229.

Henderson, D.Tree, A.Taylor, H.Khoo, V.Van As, N. (2015). SBRT for localised prostate cancer: an evaluation of toxicity with frequent prospective assessment, RADIOTHERAPY AND ONCOLOGY, Vol.115, pp.S672-1.

Henderson, D.R.Tree, A.van As, N. (2015). Stereotactic Body Radiation Therapy Planning for Localized Prostate Cancer in the PACE Phase 3 Trial: Can This Be Done Without Fused Planning MRI?, International Journal of Radiation Oncology*Biology*Physics, Vol.93 (3), p.E202.

Aitken, K.Tree, A.Taylor, H.Lalondrelle, S.Nutting, C.Hawkins, M.Khoo, V.Van As, N. (2014). Stereotactic body radiation therapy (SBRT) for extracranial oligometastases, RADIOTHERAPY AND ONCOLOGY, Vol.111, pp.S121-1.

Tree, A.C.Ostler, P.J.Hoskin, P.Dankulchai, P.Khoo, V.S.Van As, N.J. (2014). First UK experience of prostate SBRT: Acute toxicity and PSA outcomes, RADIOTHERAPY AND ONCOLOGY, Vol.111, pp.S36-1.

Tree, A.C.Khoo, V.S.Van As, N.J. (2013). Salvage stereotactic body radiotherapy in radio-recurrent prostate cancer - what dose is feasible?, EUROPEAN JOURNAL OF CANCER, Vol.49, p.S690.

Tree, A.Aluwini, S.Bryant, H.Hall, E.Incrocci, L.Kaplan, I.Ostler, P.Sanda, M.Thompson, A.van As, N. (2013). Successful Patient Acceptance of Randomization Within the Pace Study (Prostate Advances in Comparative Evidence), International Journal of Radiation Oncology*Biology*Physics, Vol.87 (2), p.S365.

Partridge, M.Tree, A.Brock, J.McNair, H.Fernandez, L.Panakis, N.Brada, M. (2009). Improving Tumour Control Probability with Active Breathing Control and Dose Escalation, CLINICAL ONCOLOGY, Vol.21 (3), p.250.

In this section

Research overview Research projects Publications